![Taylor Boyd](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Taylor Boyd
Corporate Officer/Principal en
AVALO THERAPEUTICS, INC.
.
Perfil
Taylor Boyd is Chief Business Officer at Avalo Therapeutics, Inc. since 2025.
Former roles include Chief Business Officer & Executive VP at Abzena Ltd. and Investor Relations Contact at Oxford Biomedica Plc from 2022 to 2024.
Education includes graduate studies at Wake Forest University and undergraduate studies at North Carolina State University.
Cargos activos de Taylor Boyd
| Empresas | Cargo | Inicio |
|---|---|---|
| AVALO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/10/2025 |
Antiguos cargos conocidos de Taylor Boyd.
| Empresas | Cargo | Fin |
|---|---|---|
| OXFORD BIOMEDICA PLC | Public Communications Contact | 01/01/2024 |
| ABZENA PLC | Corporate Officer/Principal | - |
Formación de Taylor Boyd.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
3
Relaciones de 1er grado
5
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Oxford Biomedica Plc
 Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
Wake Forest University
 Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
North Carolina State University
 North Carolina State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avalo Therapeutics, Inc.
 Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
Abzena Ltd.
 Abzena Ltd. BiotechnologyHealth Technology Engages in discovery, development and manufactures biologics drugs | Health Technology |
- Bolsa de valores
- Insiders
- Taylor Boyd
